Insulin syringe, retractable-needle
ARTG ID: 413350 · LC & Partners Pty Ltd · Shanghai Kindly Enterprise Development Group Co Ltd · Class IIa · Started July 12, 2023
Good Name: LC & Partners Pty Ltd - Insulin syringe, retractable-needle
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 413350
- Start Date
- July 12, 2023
- Effective Date
- July 12, 2023
- Country
- China
- Address
- No 658 Gaochao Road, Shanghai, 201803
The product intended for subcutaneous injection of U 40 or U 100 insulin into the body , the sliding sleeve helps protect against needle puncture once activated.
Access comprehensive regulatory information for Insulin syringe, retractable-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 413350 and sponsored by LC & Partners Pty Ltd, manufactured by Shanghai Kindly Enterprise Development Group Co Ltd in China. The device registration started on July 12, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.